Determination of plasma and brain concentrations of trazodone and its metabolite, l-m-chlorophenylpiperazine, by gas-liquid chromatography

S. Caccia, M. Ballabio, R. Fanelli, G. Guiso, M. G. Zanini

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

A sensitive and specific gas chromatographic procedure is described for the quantitation of trazodone and its active metabolite, 1-m-chlorphenylpiperazine (mCPP), in plasma and brain. After addition of internal standards, the samples were extracted with benzene and the extracts divided into two portions. One portion was evaporated to dryness, the residue dissolved in methanol and the solution injected into a gas chromatograph equipped with a nitrogen-selective detector, for trazodone quantitation. To the remaining half of the extracts, 100 μl of heptafluorobutyric anhydride solution were added and the metabolite was measured as the heptafluorobutyryl derivative by electron-capture detection. Gas chromatography-mass spectrometry was used to confirm the specificity of the analyses. The kinetic profile of trazodone and its metabolite was investigated after oral administration of trazodone (25 mg/kg). The parent drug and its metabolite both accumulated in brain, reaching concentrations several times those in plasma. More mCPP than the parent compound entered the brain; the ratio of the area under the curve for trazodone to mCPP in plasma was about 4, whereas in brain it was only about 0.8.

Original languageEnglish
Pages (from-to)311-318
Number of pages8
JournalJournal of Chromatography A
Volume210
Issue number2
DOIs
Publication statusPublished - Jun 5 1981

Fingerprint

Trazodone
Liquid chromatography
Metabolites
Gas chromatography
Gas Chromatography
Brain
Plasmas
heptafluorobutyric anhydride
Gases
Benzene
Gas Chromatography-Mass Spectrometry
Area Under Curve
Mass spectrometry
Oral Administration
Methanol
Nitrogen
1-(3-chlorophenyl)piperazine
Electrons
Derivatives
Detectors

ASJC Scopus subject areas

  • Analytical Chemistry
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Determination of plasma and brain concentrations of trazodone and its metabolite, l-m-chlorophenylpiperazine, by gas-liquid chromatography. / Caccia, S.; Ballabio, M.; Fanelli, R.; Guiso, G.; Zanini, M. G.

In: Journal of Chromatography A, Vol. 210, No. 2, 05.06.1981, p. 311-318.

Research output: Contribution to journalArticle

@article{72eb38e4d3cb4f1aaae0034f8f7ae9e3,
title = "Determination of plasma and brain concentrations of trazodone and its metabolite, l-m-chlorophenylpiperazine, by gas-liquid chromatography",
abstract = "A sensitive and specific gas chromatographic procedure is described for the quantitation of trazodone and its active metabolite, 1-m-chlorphenylpiperazine (mCPP), in plasma and brain. After addition of internal standards, the samples were extracted with benzene and the extracts divided into two portions. One portion was evaporated to dryness, the residue dissolved in methanol and the solution injected into a gas chromatograph equipped with a nitrogen-selective detector, for trazodone quantitation. To the remaining half of the extracts, 100 μl of heptafluorobutyric anhydride solution were added and the metabolite was measured as the heptafluorobutyryl derivative by electron-capture detection. Gas chromatography-mass spectrometry was used to confirm the specificity of the analyses. The kinetic profile of trazodone and its metabolite was investigated after oral administration of trazodone (25 mg/kg). The parent drug and its metabolite both accumulated in brain, reaching concentrations several times those in plasma. More mCPP than the parent compound entered the brain; the ratio of the area under the curve for trazodone to mCPP in plasma was about 4, whereas in brain it was only about 0.8.",
author = "S. Caccia and M. Ballabio and R. Fanelli and G. Guiso and Zanini, {M. G.}",
year = "1981",
month = "6",
day = "5",
doi = "10.1016/S0021-9673(00)97841-5",
language = "English",
volume = "210",
pages = "311--318",
journal = "Journal of Chromatography A",
issn = "0021-9673",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Determination of plasma and brain concentrations of trazodone and its metabolite, l-m-chlorophenylpiperazine, by gas-liquid chromatography

AU - Caccia, S.

AU - Ballabio, M.

AU - Fanelli, R.

AU - Guiso, G.

AU - Zanini, M. G.

PY - 1981/6/5

Y1 - 1981/6/5

N2 - A sensitive and specific gas chromatographic procedure is described for the quantitation of trazodone and its active metabolite, 1-m-chlorphenylpiperazine (mCPP), in plasma and brain. After addition of internal standards, the samples were extracted with benzene and the extracts divided into two portions. One portion was evaporated to dryness, the residue dissolved in methanol and the solution injected into a gas chromatograph equipped with a nitrogen-selective detector, for trazodone quantitation. To the remaining half of the extracts, 100 μl of heptafluorobutyric anhydride solution were added and the metabolite was measured as the heptafluorobutyryl derivative by electron-capture detection. Gas chromatography-mass spectrometry was used to confirm the specificity of the analyses. The kinetic profile of trazodone and its metabolite was investigated after oral administration of trazodone (25 mg/kg). The parent drug and its metabolite both accumulated in brain, reaching concentrations several times those in plasma. More mCPP than the parent compound entered the brain; the ratio of the area under the curve for trazodone to mCPP in plasma was about 4, whereas in brain it was only about 0.8.

AB - A sensitive and specific gas chromatographic procedure is described for the quantitation of trazodone and its active metabolite, 1-m-chlorphenylpiperazine (mCPP), in plasma and brain. After addition of internal standards, the samples were extracted with benzene and the extracts divided into two portions. One portion was evaporated to dryness, the residue dissolved in methanol and the solution injected into a gas chromatograph equipped with a nitrogen-selective detector, for trazodone quantitation. To the remaining half of the extracts, 100 μl of heptafluorobutyric anhydride solution were added and the metabolite was measured as the heptafluorobutyryl derivative by electron-capture detection. Gas chromatography-mass spectrometry was used to confirm the specificity of the analyses. The kinetic profile of trazodone and its metabolite was investigated after oral administration of trazodone (25 mg/kg). The parent drug and its metabolite both accumulated in brain, reaching concentrations several times those in plasma. More mCPP than the parent compound entered the brain; the ratio of the area under the curve for trazodone to mCPP in plasma was about 4, whereas in brain it was only about 0.8.

UR - http://www.scopus.com/inward/record.url?scp=0019726129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019726129&partnerID=8YFLogxK

U2 - 10.1016/S0021-9673(00)97841-5

DO - 10.1016/S0021-9673(00)97841-5

M3 - Article

C2 - 7263792

AN - SCOPUS:0019726129

VL - 210

SP - 311

EP - 318

JO - Journal of Chromatography A

JF - Journal of Chromatography A

SN - 0021-9673

IS - 2

ER -